Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT.
Hepatology. 2014 Apr;59(4):1262-72. doi: 10.1002/hep.26657. Epub 2014 Feb 18.
Despite activating similar signaling cascades, the type I and type III interferons (IFNs) differ in their ability to antagonize virus replication. However, it is not clear whether these cytokines induce unique antiviral states, particularly in the liver, where the clinically important hepatitis B and C viruses cause persistent infection. Here, clustering and promoter analyses of microarray-based gene expression profiling were combined with mechanistic studies of signaling pathways to dynamically characterize the transcriptional responses induced by these cytokines in Huh7 hepatoma cells and primary human hepatocytes. Type I and III IFNs differed greatly in their level of interferon-stimulated gene (ISG) induction with a clearly detectable hierarchy (IFN-β > IFN-α > IFN-λ3 > IFN-λ1 > IFN-λ2). Notably, although the hierarchy identified varying numbers of differentially expressed genes when quantified using common statistical thresholds, further analysis of gene expression over multiple timepoints indicated that the individual IFNs do not in fact regulate unique sets of genes. The kinetic profiles of IFN-induced gene expression were also qualitatively similar with the important exception of IFN-α. While stimulation with either IFN-β or IFN-λs resulted in a similar long-lasting ISG induction, IFN-α signaling peaked early after stimulation then declined due to a negative feedback mechanism. The quantitative expression hierarchy and unique kinetics of IFN-α reveal potential specific roles for individual IFNs in the immune response, and elucidate the mechanism behind previously observed differences in IFN antiviral activity. While current clinical trials are focused on IFN-λ1 as a potential antiviral therapy, the finding that IFN-λ3 invariably possesses the highest activity among type III IFNs suggests that this cytokine may have superior clinical activity.
尽管 I 型和 III 型干扰素 (IFN) 激活了相似的信号级联反应,但它们在拮抗病毒复制的能力上有所不同。然而,目前尚不清楚这些细胞因子是否会诱导独特的抗病毒状态,尤其是在肝脏中,临床重要的乙型和丙型肝炎病毒会导致持续性感染。在这里,我们将基于微阵列的基因表达谱聚类和启动子分析与信号通路的机制研究相结合,以动态描述这些细胞因子在 Huh7 肝癌细胞和原代人肝细胞中诱导的转录反应。I 型和 III 型 IFN 在诱导干扰素刺激基因 (ISG) 的水平上存在显著差异,存在明显的分层现象(IFN-β>IFN-α>IFN-λ3>IFN-λ1>IFN-λ2)。值得注意的是,尽管使用常见的统计阈值对基因表达进行量化时,确定的分层会识别出不同数量的差异表达基因,但对多个时间点的基因表达进行进一步分析表明,个体 IFN 实际上并未调节独特的基因集。IFN 诱导基因表达的动力学特征也具有相似性,IFN-α是一个重要的例外。IFN-β或 IFN-λs 的刺激会导致类似的持续 ISG 诱导,而 IFN-α 信号在刺激后早期达到峰值,然后由于负反馈机制而下降。IFN-α诱导基因表达的定量表达层次和独特动力学揭示了个体 IFN 在免疫反应中可能具有特定的作用,并阐明了先前观察到 IFN 抗病毒活性差异的背后机制。虽然目前的临床试验集中在 IFN-λ1 作为一种潜在的抗病毒治疗方法上,但 IFN-λ3 在 III 型 IFN 中始终具有最高活性的发现表明,这种细胞因子可能具有更好的临床活性。